James E. Crowe - Concepedia

Author

James E. Crowe

Vanderbilt University Medical Center ORCID

Also Known As

Agajanian, Megan J, Austin, S. Kyle, Baric, R. S., Clarence Creech, Crowe, James, Crowe, James E., Crowe, James E. Jr., De Alwis, Ruklanthi, Durbin, Anna, Durbin, Anna P.

1.3K

Publications

37.7K

Citations

H-Index

239

Concepts

All Affiliations

Vanderbilt University Medical Center Vanderbilt University Washington University in St. Louis Scripps Research Institute The University of Texas Medical Branch at Galveston

About

James E. Crowe is an author at Vanderbilt University Medical Center specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	78	211	19.3K
2	Engineering	8	8	431
3	Health Sciences	8	8	385
4	Natural Sciences	8	8	450
5	Public Health	2	2	174

James E. Crowe

377

Publications

34.5K

Citations

H-Index

Page 1

	Year	Citations
Potently neutralizing and protective human antibodies against SARS-CoV-2 Seth J. Zost, Pavlo Gilchuk, James Brett Case, Nature	2020	1.2K
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Cell Host & Microbe	2020	1.1K
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies Rita E. Chen, Xianwen Zhang, James Brett Case, Nature Medicine	2021	1K
Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children John V. Williams, Paul A. Harris, Sharon J. Tollefson, New England Journal of Medicine	2004	972
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 Matthew C. Woodruff, Richard P. Ramonell, Doan C. Nguyen, Nature Immunology	2020	772
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies Laura A. VanBlargan, John M. Errico, Peter Halfmann, Nature Medicine VaccinationTherapeutic Monoclonal AntibodiesImmunologyViral PathogenesisAntiviral Response	2022	758
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus Rui Xu, Damian C. Ekiert, Jens C. Krause, Science	2010	602
Proof of principle for epitope-focused vaccine design Bruno E. Correia, John T. Bates, Rebecca J. Loomis, Nature VaccinationEpitope-focused Vaccine DesignCross-protectionVaccine TargetImmunology	2014	567
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein Seth J. Zost, Pavlo Gilchuk, Rita E. Chen, Nature Medicine Diverse PanelViral DiagnosticsVaccine TargetViral PathogenesisImmunology	2020	532
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors Xiaocong Yu, Tshidi Tsibane, Patricia McGraw, Nature VaccinationHumoral ResponseImmunologyB CellsVaccine Design	2008	457

Page 1